Skip to content

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Alnylam Pharmaceuticals Inc

ALNY · NASDAQ

Save to watchlist

Prices as of Aug 18

$228.61+4.01 (+1.79%)Today

Market open·Aug 18

A

ALNYAlnylam Pharmaceuticals Inc$228.61+1.79%

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

Open: $226.27
52-wk high: $495.55
High: $230.91
52-wk low: $197.81
Low: $222.01
Prev close: $224.60

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$11.9B

DC
Dodge & Cox
Q2 2026 13F
$588.6M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Jul 30, 2026

Earnings came in 16.0% below what analysts expected.

Documents

Earnings releaseEX-99.1 Quarterly report10-Q

Financials

Financials

The three statements

Loading

Technicals

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

30oversold

20D volatility

128%annualized

52-week range

$228.61

$197.81$495.55

20D support

News

News

What the news says

Loading

Company

Symbol: ALNY
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $30.59B
Beta: 0.28

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

ALNY - ALNYLAM PHARMACEUTICALS, INC. - AlphaYou

Mkt cap

$30.59B

P/E

39.1x

Volume

1.60M

Fwd P/E

25.9x

Beta

0.28

P/S

6.4x

P/B

22.2x

Profit margin

+16.1%

Op margin

+17.9%

ROE

+96.6%

$564.7M

position

DS

D.E. Shaw

Q2 2026 13F

$332.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ALNY

No recent Congress trade
No recent market-voice mention

Annual report10-K

Earnings per share

$1.21-16.0%

$1.44 expected

Revenue

$1.29B

No comparable estimate

Company adjusted EPS

$1.84

From the company's release

The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.

FY 2026 guidance

$4.70B to $5.10B

No comparable estimate

Next report

What the street expects next

EPS expected

$2.32

$1.94 to $3.45

Revenue expected

$1.44B

21 analysts

Last 30 days

2up3down

Analysts cutting estimates

Estimate drift

0.12

Change in 30 days

From the release

What the company said

Revenue $1.3B.
GAAP EPS $1.21; adjusted EPS $1.84.
FY 2026 revenue guidance $4.7B to $5.1B.

$197.81recent floor

20D resistance

$290.60recent ceiling

Returns

5D +3.3%20D -15.8%60D -23.9%

Price vs moving averages

SMA20 -3.7%SMA50 -15.4%SMA200 -31.6%

Volume pace

1.46xvs prior 20D